Choi J Y, Kwon O J
Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea.
Transplant Proc. 2013 Oct;45(8):2919-24. doi: 10.1016/j.transproceed.2013.08.045.
Donor renal volume, which can be easily measured by computerized tomographic angiography with 3-dimensional reconstruction, may influence graft outcomes. Low functional renal mass and donor kidney-recipient body size mismatch can lead to progressive renal injury and poor graft function.
This single-center retrospective analysis of 51 consecutive living donor renal transplantations performed between January 2005 and December 2011 defined transplant renal volume per unit recipient body surface area (BSA; mL/m(2)). The patients were divided into 2 groups: group I (n = 31, donor-recipient BSA ratio ≤1) and group II (n = 20, BSA ratio >1). We analyzed the clinical characteristics and laboratory data of donors and recipients to ascertain correlations with, renal volumes and graft outcomes.
The renal volumes of living donors correlated with estimated glomerular filtration ratios (eGFR; r = .314, P = .025). Serum creatinine after renal transplantation correlated with transplanted renal volume at 1, 3, and 12 months (r = -.319, P = .048; r = -.407, P = .010; r = -.472, P = .002). Serum eGFR also correlated with transplanted renal volume at 3 and 12 months after renal transplantation (r = .318, P = .049 and r = .388, P = .015). There were no significant differences between groups for acute or chronic rejection, infection or delayed graft function. However, serum creatinine levels were higher (P = .011, P = .022, and P = .007) and serum eGFR significantly lower in group I at 1, 3, 6, and 12 months after renal transplantation (P = .036, P = .042, P = .042, and P = .049, respectively). There was no significant difference in graft survival.
Renal volume of living donors may reflect renal function and have a significant impact on graft outcomes. Renal volume matching should be considered to select donor-recipient pairs for living donor renal transplantation.
供体肾体积可通过计算机断层血管造影三维重建轻松测量,可能影响移植肾结局。低功能性肾质量以及供肾与受者体型不匹配可导致进行性肾损伤和移植肾功能不佳。
对2005年1月至2011年12月期间连续进行的51例活体供肾肾移植进行单中心回顾性分析,定义每单位受者体表面积(BSA;mL/m²)的移植肾体积。患者分为两组:I组(n = 31,供者 - 受者BSA比值≤1)和II组(n = 20,BSA比值>1)。我们分析了供者和受者的临床特征及实验室数据,以确定与肾体积和移植肾结局的相关性。
活体供者的肾体积与估计肾小球滤过率(eGFR;r = 0.314,P = 0.025)相关。肾移植后血清肌酐在1、3和12个月时与移植肾体积相关(r = -0.319,P = 0.048;r = -0.407,P = 0.010;r = -0.472,P = 0.002)。血清eGFR在肾移植后3个月和12个月时也与移植肾体积相关(r = 0.318,P = 0.049和r = 0.388,P = 0.015)。急性或慢性排斥反应、感染或移植肾功能延迟在两组之间无显著差异。然而,肾移植后1、3、6和12个月时,I组的血清肌酐水平较高(P = 0.011、P = 0.022和P = 0.007),血清eGFR显著较低(分别为P = 0.036、P = 0.042、P = 0.042和P = 0.049)。移植肾存活率无显著差异。
活体供者的肾体积可能反映肾功能,并对移植肾结局有显著影响。在选择活体供肾肾移植的供受者对时应考虑肾体积匹配。